BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17702750)

  • 21. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
    Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
    J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
    Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance.
    Xu M; Petraschka M; McLaughlin JP; Westenbroek RE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Terman GW; Chavkin C
    J Neurosci; 2004 May; 24(19):4576-84. PubMed ID: 15140929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia.
    Lawson KP; Nag S; Thompson AD; Mokha SS
    Pain; 2010 Dec; 151(3):806-815. PubMed ID: 20926192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in mice.
    Jackson KJ; Jackson A; Carroll FI; Damaj MI
    Neuropharmacology; 2015 Oct; 97():270-4. PubMed ID: 26044637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
    Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
    J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of kappa opioid receptor ligand potency, efficacy and desensitization using a real-time membrane potential assay.
    Zhao Y; Joshi AA; Aldrich JV; Murray TF
    Biomed Pharmacother; 2021 Nov; 143():112173. PubMed ID: 34536757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects.
    Huang P; Chen C; Cao D; Huang M; Liu-Chen LY
    Neuropharmacology; 2022 Jan; 202():108860. PubMed ID: 34736959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.
    Eans SO; Ganno ML; Reilley KJ; Patkar KA; Senadheera SN; Aldrich JV; McLaughlin JP
    Br J Pharmacol; 2013 May; 169(2):426-36. PubMed ID: 23425081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
    Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
    Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. kappa Opioid receptor selective affinity labels: electrophilic benzeneacetamides as kappa-selective opioid antagonists.
    Chang AC; Takemori AE; Ojala WH; Gleason WB; Portoghese PS
    J Med Chem; 1994 Dec; 37(26):4490-8. PubMed ID: 7799399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prior activation of kappa opioid receptors by U50,488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning.
    McLaughlin JP; Land BB; Li S; Pintar JE; Chavkin C
    Neuropsychopharmacology; 2006 Apr; 31(4):787-94. PubMed ID: 16123754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.
    Jamshidi RJ; Jacobs BA; Sullivan LC; Chavera TA; Saylor RM; Prisinzano TE; Clarke WP; Berg KA
    J Pharmacol Exp Ther; 2015 Nov; 355(2):174-82. PubMed ID: 26297384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zyklophin, a systemically active selective kappa opioid receptor peptide antagonist with short duration of action.
    Aldrich JV; Patkar KA; McLaughlin JP
    Proc Natl Acad Sci U S A; 2009 Oct; 106(43):18396-401. PubMed ID: 19841255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice.
    Hough LB; Nalwalk JW; Chen Y; Schuller A; Zhu Y; Zhang J; Menge WM; Leurs R; Timmerman H; Pintar JE
    Brain Res; 2000 Oct; 880(1-2):102-8. PubMed ID: 11032994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex difference in κ-opioid receptor (KOPR)-mediated behaviors, brain region KOPR level and KOPR-mediated guanosine 5'-O-(3-[35S]thiotriphosphate) binding in the guinea pig.
    Wang YJ; Rasakham K; Huang P; Chudnovskaya D; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2011 Nov; 339(2):438-50. PubMed ID: 21841040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain.
    Edwards KA; Havelin JJ; Mcintosh MI; Ciccone HA; Pangilinan K; Imbert I; Largent-Milnes TM; King T; Vanderah TW; Streicher JM
    J Pain; 2018 Jun; 19(6):612-625. PubMed ID: 29371114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization.
    Chen C; Chiu YT; Wu W; Huang P; Mann A; Schulz S; Liu-Chen LY
    Biochem J; 2016 Feb; 473(4):497-508. PubMed ID: 26635353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.
    Land BB; Bruchas MR; Schattauer S; Giardino WJ; Aita M; Messinger D; Hnasko TS; Palmiter RD; Chavkin C
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19168-73. PubMed ID: 19864633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.